These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8428405

  • 1. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ, Johnson KL, McConnell J.
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [Abstract] [Full Text] [Related]

  • 2. The use of transdermal clonidine in the hypertensive patient with chronic renal failure.
    Lowenthal DT, Saris SD, Paran E, Cristal N.
    Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406
    [Abstract] [Full Text] [Related]

  • 3. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC, Herron J, Zellner S.
    Clin Ther; 1991 Jan; 13(4):471-81. PubMed ID: 1933999
    [Abstract] [Full Text] [Related]

  • 4. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM, Matzek KM, Hughes EM, Johnson PA, Sharon GS.
    Clin Ther; 1989 Nov; 11(3):398-408. PubMed ID: 2743374
    [Abstract] [Full Text] [Related]

  • 7. Transdermal clonidine for hypertensive patients.
    Popli S, Stroka G, Ing TS, Daugirdas JT, Norusis MJ, Hano JE, Gandhi VC.
    Clin Ther; 1983 Nov; 5(6):624-8. PubMed ID: 6627288
    [Abstract] [Full Text] [Related]

  • 8. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR.
    N Z Med J; 1987 Nov 25; 100(836):711-3. PubMed ID: 3330602
    [Abstract] [Full Text] [Related]

  • 9. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
    Kellaway GS, Lubbe WF.
    N Z Med J; 1986 Sep 24; 99(810):711-4. PubMed ID: 3547202
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R, Tagawa T, Ishida T, Naruse T.
    Arzneimittelforschung; 1996 Mar 24; 46(3):261-8. PubMed ID: 8901146
    [Abstract] [Full Text] [Related]

  • 11. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C, Morton N, Kelley S, Metz S.
    J Hypertens Suppl; 1985 Dec 24; 3(4):S81-4. PubMed ID: 3868715
    [Abstract] [Full Text] [Related]

  • 12. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May 24; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 13. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A, Benavides B, Quirós P, Jiménez-Moreno J, Figueroa E, Fernández-Marchena D, García-Pérez MA, Fernández-Ruiz E.
    Nefrologia; 2006 May 24; 26(6):695-702. PubMed ID: 17227247
    [Abstract] [Full Text] [Related]

  • 14. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
    Groth H, Vetter H, Knüsel J, Boerlin HJ, Walger P, Baumgart P, Wehling M, Siegenthaler W, Vetter W.
    Schweiz Med Wochenschr; 1983 Dec 10; 113(49):1841-5. PubMed ID: 6676936
    [Abstract] [Full Text] [Related]

  • 15. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S, Nath V, Coyne DW.
    Am J Nephrol; 2007 Dec 10; 27(5):522-9. PubMed ID: 17700014
    [Abstract] [Full Text] [Related]

  • 16. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
    Ambrosioni E.
    Ann Ital Med Int; 1994 Oct 10; 9 Suppl():54S-57S. PubMed ID: 7857759
    [Abstract] [Full Text] [Related]

  • 17. [Urapidil (Ebrantil) use in patients on chronic hemodialysis].
    Krawczyk W, Steć E.
    Wiad Lek; 1990 Jun 01; 43(11):501-5. PubMed ID: 2219915
    [Abstract] [Full Text] [Related]

  • 18. Postoperative analgesia using a low-dose, oral-transdermal clonidine combination: lack of clinical efficacy.
    Owen MD, Fibuch EE, McQuillan R, Millington WR.
    J Clin Anesth; 1997 Feb 01; 9(1):8-14. PubMed ID: 9051539
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF, Graif JL, Husebye DG, Maddy MM, McArthur CD, Path MJ, O'Connell MB, Iber C, Davidman M.
    Arch Intern Med; 1989 Jul 01; 149(7):1551-6. PubMed ID: 2525897
    [Abstract] [Full Text] [Related]

  • 20. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA, Materson BJ, Reda DJ, Hamburger RJ, Williams DW, Smith MH.
    Clin Nephrol; 1997 May 01; 47(5):310-5. PubMed ID: 9181278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.